Real-life use of cidofovir for the treatment of severe monkeypox cases

J Med Virol. 2023 Jan;95(1):e28218. doi: 10.1002/jmv.28218. Epub 2022 Oct 20.

Authors

Angelo Roberto Raccagni¹, Caterina Candela¹, Elena Bruzzesi¹, Davide Mileto², Diana Canetti³, Alberto Rizzo^{2

4}, Antonella Castagna^{1

3}, Silvia Nozza³

Affiliations

¹ Infectious Diseases Unit, Vita-Salute San Raffaele University, Milan, Italy.
² Laboratory of Clinical Microbiology, Virology and Bioemergencies, Ospedale Sacco, Milan, Italy.
³ Infectious Diseases Unit, San Raffaele Scientific Institute, Milan, Italy.
⁴ Laboratory of Clinical Microbiology, Virology and Bioemergencies, University of Milan, Milan, Italy.

PMID: 36229902
DOI: 10.1002/jmv.28218

No abstract available

Publication types

Letter

MeSH terms

Antiviral Agents / therapeutic use
Cidofovir / therapeutic use
Humans
Mpox (monkeypox)*
Organophosphonates* / therapeutic use

Substances

Cidofovir
Antiviral Agents
Organophosphonates